Transplant Beats Bortezomib-Based Therapy for MM Transplant Beats Bortezomib-Based Therapy for MM

In a large randomized trial, upfront autologous transplantation bested bortezomib-based intensification therapy for patients with multiple myeloma.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news